4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Qyuns Therapeutics Co., Ltd. (2509) operates in the Biotechnology industry and is headquartered in Taizhou, China with about 337 employees. Its market capitalization is roughly CNY 4 billion. In the fiscal year ended 2025-12-31, 2509 reported CNY 807M in revenue and CNY 314M in net income.
Qyuns Therapeutics Co., Ltd., a clinical-stage biotech company, engages in the research and development of biologic therapies for autoimmune and allergic diseases in China.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 807M | CNY 159M | CNY 0M | CNY 0M | — |
| Gross Profit | CNY 714M | CNY 92M | CNY 0M | — | — |
| Operating Income (EBIT) | CNY 333M | (CNY 342M) | (CNY 515M) | (CNY 325M) | — |
| Net Income | CNY 314M | (CNY 336M) | (CNY 508M) | (CNY 298M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 1.6B | CNY 984M | CNY 796M | CNY 1.0B | — |
| Total Liabilities | CNY 921M | CNY 763M | CNY 495M | CNY 374M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2509 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms